Abiopharma

Envista Schedules Fourth Quarter 2025 Earnings Call

Miljkovic Milos 🔴 sold 3.6K shares of Cartesian Therapeutics, Inc. (RNAC) at $6.82 Transaction Date: Jan 06, 2026 | Filing ID: 000046

Davis Blaine 🔴 sold 10.6K shares of Cartesian Therapeutics, Inc. (RNAC) at $6.82 Transaction Date: Jan 06, 2026 | Filing ID: 000045

Schuth Alexander O. 🔴 sold 17.2K shares of Denali Therapeutics Inc. (DNLI) at $16.50 Transaction Date: Jan 06, 2026 | Filing ID: 000005

New Form 424B3 - GT Biopharma, Inc. Filed: 2026-01-08 AccNo: 0001493152-26-000976 Size: 10 KB

DALL·E Version Comparison

📋 Heyman Richard A. (Director) plans to sell 12K shares of Enliven Therapeutics, Inc. (at $15.47 each, total $190K) Filed: Jan 08, 2026 | ID: 000003

📋 Boulding Mark Elliott (Officer) plans to sell 1K shares of PTC THERAPEUTICS, INC. (at $76.45 each, total $98K) Filed: Jan 08, 2026 | ID: 000217

(10% Negative) Verastem, Inc. (VSTM) Announces Clinical Trial Timeline Adjustment

(99% Positive) Canopy Growth Corp (CGC) Announces Business Combination

ResMed Inc. Q2 2026 Financial Results Conference Call

(99% Neutral) AGENUS INC. (AGEN) Announces Business Combination

(84% Neutral) ImmuCell Corporation (ICCC) Announces Business Combination

Gallagher Cam 🟢 acquired 67.0K shares of Opus Genetics, Inc. (IRD) Transaction Date: Jan 06, 2026 | Filing ID: 000088

📋 ERIC J LOUMEAU (Officer) plans to sell 2K shares of ANAPTYSBIO, INC (at $43.91 each, total $89K) Filed: Jan 08, 2026 | ID: 000003